Keith Lamont Cummings - Net Worth and Insider Trading

Keith Lamont Cummings Net Worth

The estimated net worth of Keith Lamont Cummings is at least $4 Million dollars as of 2024-11-05. Keith Lamont Cummings is the CFO of Pliant Therapeutics Inc and owns about 282,115 shares of Pliant Therapeutics Inc (PLRX) stock worth over $4 Million. Details can be seen in Keith Lamont Cummings's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Keith Lamont Cummings has not made any transactions after 2024-07-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Keith Lamont Cummings

To

Keith Lamont Cummings Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Keith Lamont Cummings owns 1 companies in total, including Pliant Therapeutics Inc (PLRX) .

Click here to see the complete history of Keith Lamont Cummings’s form 4 insider trades.

Insider Ownership Summary of Keith Lamont Cummings

Ticker Comapny Transaction Date Type of Owner
PLRX Pliant Therapeutics Inc 2024-07-10 Chief Financial Officer

Keith Lamont Cummings Latest Holdings Summary

Keith Lamont Cummings currently owns a total of 1 stock. Keith Lamont Cummings owns 282,115 shares of Pliant Therapeutics Inc (PLRX) as of July 10, 2024, with a value of $4 Million.

Latest Holdings of Keith Lamont Cummings

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PLRX Pliant Therapeutics Inc 2024-07-10 282,115 14.21 4,007,444

Holding Weightings of Keith Lamont Cummings


Keith Lamont Cummings Form 4 Trading Tracker

According to the SEC Form 4 filings, Keith Lamont Cummings has made a total of 7 transactions in Pliant Therapeutics Inc (PLRX) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Pliant Therapeutics Inc is the sale of 10,911 shares on July 10, 2024, which brought Keith Lamont Cummings around $126,131.

Insider Trading History of Keith Lamont Cummings

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Keith Lamont Cummings Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Keith Lamont Cummings Ownership Network

Ownership Network List of Keith Lamont Cummings

No Data

Ownership Network Relation of Keith Lamont Cummings

Insider Network Chart

Keith Lamont Cummings Owned Company Details

What does Pliant Therapeutics Inc do?

Who are the key executives at Pliant Therapeutics Inc?

Keith Lamont Cummings is the Chief Financial Officer of Pliant Therapeutics Inc. Other key executives at Pliant Therapeutics Inc include Chief Business Officer Hans Hull , Chief Medical Officer Eric Lefebvre , and director & President and CEO Bernard Coulie .

Pliant Therapeutics Inc (PLRX) Insider Trades Summary

Over the past 18 months, Keith Lamont Cummings made 3 insider transaction in Pliant Therapeutics Inc (PLRX) with a net sale of 40,463. Other recent insider transactions involving Pliant Therapeutics Inc (PLRX) include a net sale of 72,542 shares made by Hans Hull , a net sale of 30,386 shares made by Mike Ouimette , and a net sale of 134,581 shares made by Bernard Coulie .

In summary, during the past 3 months, insiders sold 0 shares of Pliant Therapeutics Inc (PLRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 322,907 shares of Pliant Therapeutics Inc (PLRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 322,907 shares.

Pliant Therapeutics Inc (PLRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Pliant Therapeutics Inc Insider Transactions

No Available Data

Keith Lamont Cummings Mailing Address

Above is the net worth, insider trading, and ownership report for Keith Lamont Cummings. You might contact Keith Lamont Cummings via mailing address: C/o Pliant Therapeutics, Inc., 260 Littlefield Avenue, South San Francisco Ca 94080.